Literature DB >> 9655335

Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

B O Villoutreix1, B Dahlbäck.   

Abstract

Factor V (FV) is a large (2,196 amino acids) nonenzymatic cofactor in the coagulation cascade with a domain organization (A1-A2-B-A3-C1-C2) similar to the one of factor VIII (FVIII). FV is activated to factor Va (FVa) by thrombin, which cleaves away the B domain leaving a heterodimeric structure composed of a heavy chain (A1-A2) and a light chain (A3-C1-C2). Activated protein C (APC), together with its cofactor protein S (PS), inhibits the coagulation cascade via limited proteolysis of FVa and FVIIIa (APC cleaves FVa at residues R306, R506, and R679). The A domains of FV and FVIII share important sequence identity with the plasma copper-binding protein ceruloplasmin (CP). The X-ray structure of CP and theoretical models for FVIII have been recently reported. This information allowed us to build a theoretical model (994 residues) for the A domains of human FV/FVa (residues 1-656 and 1546-1883). Structural analysis of the FV model indicates that: (a) the three A domains are arranged in a triangular fashion as in the case of CP and the organization of these domains should remain essentially the same before and after activation; (b) a Type II copper ion is located at the A1-A3 interface; (c) residues R306 and R506 (cleavage sites for APC) are both solvent exposed; (d) residues 1667-1765 within the A3 domain, expected to interact with the membrane, are essentially buried; (e) APC does not bind to FVa residues 1865-1874. Several other features of factor V/Va, like the R506Q and A221V mutations; factor Xa (FXa) and human neutrophil elastase (HNE) cleavages; protein S, prothrombin and FXa binding, are also investigated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655335      PMCID: PMC2144041          DOI: 10.1002/pro.5560070607

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  84 in total

1.  Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.

Authors:  D Lu; M Kalafatis; K G Mann; G L Long
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

2.  Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.

Authors:  M J Heeb; Y Kojima; T M Hackeng; J H Griffin
Journal:  Protein Sci       Date:  1996-09       Impact factor: 6.725

3.  Proposed structure of the A domains of factor VIII by homology modelling.

Authors:  Y Pan; T DeFay; J Gitschier; F E Cohen
Journal:  Nat Struct Biol       Date:  1995-09

4.  Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.

Authors:  C Aparicio; B Dahlbäck
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

5.  Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.

Authors:  A Wei; H Rubin; B S Cooperman; D W Christianson
Journal:  Nat Struct Biol       Date:  1994-04

6.  Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.

Authors:  K Váradi; J Rosing; G Tans; I Pabinger; B Keil; H P Schwarz
Journal:  Thromb Haemost       Date:  1996-08       Impact factor: 5.249

7.  Characterization of the molecular defect in factor VR506Q.

Authors:  M Kalafatis; R M Bertina; M D Rand; K G Mann
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

8.  The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

Authors:  P J Lenting; J W van de Loo; M J Donath; J A van Mourik; K Mertens
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

9.  Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity.

Authors:  J M Murray; M D Rand; J O Egan; S Murphy; H C Kim; K G Mann
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

10.  Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  J Rosing; L Hoekema; G A Nicolaes; M C Thomassen; H C Hemker; K Varadi; H P Schwarz; G Tans
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

View more
  8 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing.

Authors:  Emily B Lurier; Donald Dalton; Will Dampier; Pichai Raman; Sina Nassiri; Nicole M Ferraro; Ramakrishan Rajagopalan; Mahdi Sarmady; Kara L Spiller
Journal:  Immunobiology       Date:  2017-02-20       Impact factor: 3.144

3.  Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.

Authors:  B O Villoutreix; D G Covell; A M Blom; A Wallqvist; U Friedrich; B Dahlbäck
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

Review 4.  Progress in the understanding of the protein C anticoagulant pathway.

Authors:  Björn Dahlbäck
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

5.  Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.

Authors:  Abed R Zeibdawi; Jean E Grundy; Bogna Lasia; Edward L G Pryzdial
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

6.  Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis.

Authors:  Mårten Steen; Sinh Tran; Ludovic Autin; Bruno O Villoutreix; Ann-Louise Tholander; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

7.  Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.

Authors:  Andrew J Gale; Xiao Xu; Jean-Luc Pellequer; Elizabeth D Getzoff; John H Griffin
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

Review 8.  Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.

Authors:  Y Zenmei Ohkubo; Jesper J Madsen
Journal:  Thromb Haemost       Date:  2021-07-02       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.